Discovery and Evaluation of 4-(2-(4-chloro-1 H -pyrazol-1-yl)ethylamino)-3-(6-(1-(3-fluoropropyl)piperidin-4-yl)-4-methyl-1 H -benzo[ d ]imidazol-2-yl)pyridin-2(1 H )-one (BMS-695735), an Orally Efficacious Inhibitor of Insulin-like Growth Factor-1 Receptor Kinase with Broad Spectrum in Vivo Antitumor Activity